Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer

被引：0
|
作者：
Francesca Sanguedolce
Antonella Cormio
Paolo Massenio
Maria C. Pedicillo
Simona Cagiano
Francesca Fortunato
Beppe Calò
Giuseppe Di Fino
Giuseppe Carrieri
Pantaleo Bufo
Luigi Cormio
机构：
[1] University of Foggia,Department of Pathology
[2] University of Bari,Department of Biosciences, Biotechnologies, and Biopharmaceutics
[3] University of Foggia,Department of Urology
[4] University of Foggia,Department of Epidemiology and Public Health
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
Non-muscle-invasive bladder cancer; HER-2; MLH1; MSH2; Immunohistochemistry; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：637 / 644
页数：7
相关论文
共 50 条
  • [21] Absence of mismatch repair deficiency in gastric lymphoma: an immunohistochemical study of mlh1 and msh2 protein expression
    Cuilliere-Dartigues, P.
    Fabiani, B.
    Dumont, S.
    Copie-Bergman, C.
    Couvelard, A.
    Molina, T.
    Duval, A.
    Flejou, J. F.
    VIRCHOWS ARCHIV, 2007, 451 (05) : 983 - 984
  • [22] MISMATCH REPAIR PROTEINS (MLH1, MSH2, MSH6) AS A PREDICTIVE MARKER FOR RADIOSENSITIVITY IN RECTAL CANCER.
    Park, C.
    Kim, H.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 613 - 613
  • [23] MLH1 and MSH2 mismatch repair protein profile using immunohistochemistry in Nepalese colorectal cancer patients
    Bhattarai, Matrika
    Juhari, Wan Khairunnisa Wan
    Lama, Raju
    Pun, Chin Bahadur
    Yusof, Wardah
    Rahman, Wan Faiziah Wan Abdul
    Zakaria, Andee Dzulkarnaen
    Noordin, Khairul Bariah Ahmad Amin
    Shrestha, Tilak R.
    Zilfalil, Bin Alwi
    MEDICAL JOURNAL OF INDONESIA, 2020, 29 (02) : 183 - 189
  • [24] An Evaluation of the Immunohistochemical Expression of Mismatch Repair Proteins (MSH2, MSH6, MLH1, and PMS2) in Prostate Adenocarcinoma
    Javeed, Saira
    Chughtai, Anila
    Zafar, Ghazi
    Khalid, Fatima
    Batool, Ayma
    Chughtai, Akhtar S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [25] Expressional analysis of MLH1 and MSH2 in breast cancer
    Malik, Saima Shakil
    Masood, Nosheen
    Asif, Muhammad
    Ahmed, Parvez
    Shah, Zafar Ullah
    Khan, Jahangir Sarwar
    CURRENT PROBLEMS IN CANCER, 2019, 43 (02) : 97 - 105
  • [26] Cancer Risks for MLH1 and MSH2 Mutation Carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel D.
    Lindor, Noralane M.
    Macrae, Finlay A.
    Clendenning, Mark
    Antill, Yoland C.
    Thibodeau, Stephen N.
    Casey, Graham
    Gallinger, Steve
    Le Marchand, Loic
    Newcomb, Polly A.
    Haile, Robert W.
    Young, Graeme P.
    James, Paul A.
    Giles, Graham G.
    Gunawardena, Shanaka R.
    Leggett, Barbara A.
    Gattas, Michael
    Boussioutas, Alex
    Ahnen, Dennis J.
    Baron, John A.
    Parry, Susan
    Goldblatt, Jack
    Young, Joanne P.
    Hopper, John L.
    Jenkins, Mark A.
    HUMAN MUTATION, 2013, 34 (03) : 490 - 497
  • [27] MSH2 and MLH1 immunodetection and the prognosis of colon cancer
    Perrin, J
    Monges, G
    Parriaux, D
    Noguchi, T
    Giovannini, MH
    Giovannini, M
    Delpero, JR
    Birnbaum, D
    Monges, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (05) : 891 - 895
  • [28] Risks of cancer for MLH1 and MSH2 mutation carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel
    Thibodeau, Stephen N.
    Casey, Graham
    Lindor, Noralane M.
    Gallinger, Steve
    Le Marchand, Loic
    Haile, Robert
    Newcomb, Polly
    Hopper, John L.
    Jenkins, Mark A.
    GENETIC EPIDEMIOLOGY, 2009, 33 (08) : 811 - 811
  • [29] MLH1 and MSH2 immunolabeling in carcinomas: High frequency of MLH1 loss of expression in endometrial carcinoma.
    Smith, KD
    Bronner, MP
    Haggin, RC
    Schmidt, RA
    LABORATORY INVESTIGATION, 1999, 79 (01) : 85A - 85A
  • [30] MLH1, PMS1, AND MSH2 INTERACTIONS DURING THE INITIATION OF DNA MISMATCH REPAIR IN YEAST
    PROLLA, TA
    PANG, QS
    ALANI, E
    KOLODNER, RD
    LISKAY, RM
    SCIENCE, 1994, 265 (5175) : 1091 - 1093
12345